Panome Bio Inc.
What matters now
- 3 directorsboard
3 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
- Nov 14, 2024Form D equity offering · $6.0M (form d sold) · 6 investorsFact Form D · “Panome Bio Inc. filed Form D: $6,000,000 sold of $6,000,000, Biotechnology”
- Edward Weinstein Executive Officer/Director sec.gov
- TOM Cohen Executive Officer sec.gov
- David Smoller Director Fact
- ROB Capone Director Fact
- Deval Lashkari Director Fact
- Nov 21, 2024Panome Bio Inc. filed Form D: $6,000,000 sold of $6,000,000, BiotechnologyForm D filed Fact Form D
Every observation on this company
- Entity type: Corporation Nov 21, 2024 Fact Form D
- Form D industry group: Biotechnology Nov 21, 2024 Fact Form D
- Amendment: false Nov 21, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Nov 21, 2024 Fact Form D
- Incorporated: withinFiveYears Nov 21, 2024 Fact Form D
- Jurisdiction: Delaware Nov 21, 2024 Fact Form D
- Amount sold (Form D): $6.0M Nov 21, 2024 Fact Form D
- Offering amount (Form D): $6.0M Nov 21, 2024 Fact Form D
- Exemptions: 06b Nov 21, 2024 Fact Form D
- First sale: 2024-11-14 Nov 21, 2024 Fact Form D
- Investors (Form D): 6 Nov 21, 2024 Fact Form D
- Minimum investment (Form D): 25,000 Nov 21, 2024 Fact Form D
- Securities offered: equity Nov 21, 2024 Fact Form D
- Office address: Nov 21, 2024 Fact Form D
- Year of incorporation: 2022 Nov 21, 2024 Fact Form D
Record history
- Form D filed2024-11-21source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.